Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Amortizatization of Intangibles (2020 - 2025)

Tango Therapeutics has reported Amortizatization of Intangibles over the past 6 years, most recently at -$5.7 million for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at -$5.7 million for Q4 2025, down 564.84% from a year ago — trailing twelve months through Dec 2025 was -$2.7 million (up 41.78% YoY), and the annual figure for FY2025 was -$2.7 million, up 41.78%.
  • Amortizatization of Intangibles for Q4 2025 was -$5.7 million at Tango Therapeutics, down from $973000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for TNGX hit a ceiling of $4.6 million in Q4 2023 and a floor of -$5.7 million in Q4 2025.
  • Median Amortizatization of Intangibles over the past 5 years was $288500.0 (2021), compared with a mean of -$10500.0.
  • Peak annual rise in Amortizatization of Intangibles hit 425.62% in 2023, while the deepest fall reached 807.49% in 2023.
  • Tango Therapeutics' Amortizatization of Intangibles stood at $321000.0 in 2021, then skyrocketed by 174.77% to $882000.0 in 2022, then soared by 425.62% to $4.6 million in 2023, then plummeted by 118.46% to -$856000.0 in 2024, then plummeted by 564.84% to -$5.7 million in 2025.
  • The last three reported values for Amortizatization of Intangibles were -$5.7 million (Q4 2025), $973000.0 (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.